Suchergebnisse - "Molife, L R"

PubPharm (3)

1

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib

enthalten in: Targeted oncology | 2016

von Mateo, J. | Moreno, V. | Gupta, A. | +15

2

Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation : a multistudy analysis of response rates and safety

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Matulonis, U. | Penson, R. | Domchek, S. | +10

3

Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Sandhu, S. | Omlin, A. | Hylands, L. | +21

1
[1]